Pacific Biosciences Gains as HudsonAlpha Picks Sequel System
Pacific Biosciences (PACB) sees increasing use of Sequel Sequencing System in pediatric and plant biologic case studies. Pacific Biosciences of Califo.....»»
Hedge Funds Have Never Been More Bullish On Pacific Biosciences of California, Inc. (PACB)
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done we.....»»
Pacific Biosciences Offers Insights on Aedes aegypti Genome
Pacific Biosciences (PACB) uses its flagship Single Molecule, Real-Time technology to sequence the h.....»»
Pacific Biosciences announces LabCorp"s addition of PacBio Sequel II Systems
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pacific Biosciences of California Becomes Oversold (PACB)
Dividend Channel.....»»
Hedge Funds Have Never Been This Bullish On Pacific Biosciences of California, Inc. (PACB)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfol.....»»
RSI Alert: Pacific Biosciences of California (PACB) Now Oversold
Dividend Channel.....»»
Pacific Biosciences of California is Now Oversold (PACB)
Dividend Channel.....»»
Can Core Unit Drive Pacific Biosciences" (PACB) Q1 Earnings?
Pacific Bio.....»»
Pacific Biosciences Sequel installs could be light in Q1, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pacific Biosciences of California"s (PACB) CEO Mike Hunkapiller on Q1 2018 Results - Earnings Call Transcript
Pacific Biosciences of California"s (PACB) CEO Mike Hunkapiller on Q1 2018 Results - Earnings Call Transcript.....»»
Pacific Biosciences (PACB) Loss Wider Than Expected in Q1
Pacific Biosciences (PACB) Q1 earni.....»»
Pacific Biosciences of California (PACB) CEO Mike Hunkapiller on Q2 2018 Results - Earnings Call Transcript
Pacific Biosciences of California (PACB) CEO Mike Hunkapiller on Q2 2018 Results - Earnings Call Transcript.....»»
Pacific Biosciences" Sequel Sees Solid Q2, Competition Rife
Pacific Biosciences (P.....»»
Illumina Buys Rival Pacific Biosciences In $1.2B Deal
Shares of Pacific Biosciences of California (NASDAQ: PACB), a developer of systems for gene sequencing, are soaring to a two-year high in pre-market trading. read more.....»»
Illumina’s Growth Shows No Signs of Slowing Down
Illumina's recent acquisition of Pacific Biosciences of California strongly strengthens its product offering and ensures growth for years to comeRelated Stocks: ILMN, PACB, TMO, A, QGEN,.....»»
Pacific Biosciences of California Enters Oversold Territory (PACB)
Dividend Channel.....»»